Advertisement
Advertisement
IART
Integra LifeSciences Holdings
12.80
USDSponsored
+0.56
+4.59%
Oct 29, 10:57 UTC -4
Open
Integra LifeSciences Holdings (IART) Earnings
IART Earnings Reports
Positive Surprise Ratio
IART beat 27 of 44 last estimates.
61%
Next Report
Date of Next Report
Feb 24, 2027
Estimate for Q4 26 (Revenue/ EPS)
$433.73M
/$0.70
Implied change from Q3 26 (Revenue/ EPS)
+5.48%
/+18.64%
Implied change from Q4 25 (Revenue/ EPS)
-0.27%
/-15.66%
Integra LifeSciences Holdings earnings per share and revenue
On Oct 21, 2026, IART reported earnings of 0.59 USD per share (EPS) for Q3 26, beating the estimate of 0.57 USD, resulting in a 3.04% surprise. Revenue reached 411.18 million, compared to an expected 422.40 million, with a -2.66% difference. The market reacted with a -21.19% price change (close before vs. close after earnings).
Looking ahead to Q4 26, 8 analysts forecast an EPS of 0.70 USD, with revenue projected to reach 433.73 million USD, implying an increase of 18.64% EPS, and increase of 5.48% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Beta Bionics, Inc. Common Stock
Report Date
Oct 27, 2026 For Q3 26
Estimate
-$0.53
Actual
-$0.52
Surprise
+2.73%
OrthoPediatrics Corp. Common Stock
Report Date
Oct 27, 2026 For Q3 26
Estimate
-$0.21
Actual
-$0.23
Surprise
-4.88%
ClearPoint Neuro, Inc. Common Stock
Report Date
Oct 28, 2026 For Q3 26
Estimate
-$0.32
Actual
-$0.24
Surprise
+25.30%
Thermo Fisher Scientific, Inc.
Report Date
Oct 21, 2026 For Q3 26
Estimate
$6.46
Actual
$6.68
Surprise
+3.29%
Intuitive Surgical Inc.
Report Date
Oct 20, 2026 For Q3 26
Estimate
$2.69
Actual
$3.00
Surprise
+11.29%
IQVIA Holdings Inc.
Report Date
Oct 27, 2026 For Q3 26
Estimate
$3.30
Actual
$3.34
Surprise
+0.97%
Glaukos Corporation
Report Date
Oct 28, 2026 For Q3 26
Estimate
-$0.09
Actual
$0.47
Surprise
+611.98%
Axogen, Inc. Common Stock
Report Date
Oct 28, 2026 For Q3 26
Estimate
$0.14
Actual
$0.21
Surprise
+47.06%
FAQ
What were Integra LifeSciences Holdings's earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, Integra LifeSciences Holdings reported EPS of $0.59, beating estimates by 3.04%, and revenue of $411.18M, -2.66% below expectations.
How did the market react to Integra LifeSciences Holdings's Q3 2026 earnings?
The stock price moved down -21.19%, changed from $16.09 before the earnings release to $12.68 the day after.
When is Integra LifeSciences Holdings expected to report next?
The next earning report is scheduled for Feb 24, 2027.
What are the forecasts for Integra LifeSciences Holdings's next earnings report?
Based on 8
analysts, Integra LifeSciences Holdings is expected to report EPS of $0.70 and revenue of $433.73M for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.